Last reviewed · How we verify
NCT05908903
A Clinical Study on the Improvement of Sleep Quality, Skin Condition and Life Status After Taking Sleep Aid Drinks
NA trial testing Drinks with active ingredients such as poria and GABA in Sleep Disorder in 70 participants. Completed in 7 August 2022.
7 August 2022
Quick facts
| Lead sponsor | Botanee Group Co., Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 70 |
| Start date | 9 July 2022 |
| Primary completion | 7 August 2022 |
| Estimated completion | 7 August 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- Drinks with active ingredients such as poria and GABA
Conditions studied
- Sleep Disorder — all drugs for Sleep Disorder →
Sponsor
Botanee Group Co., Ltd.
Who can join
Adults 25 to 55, female only, with Sleep Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective of the study is to observe changes in the subjects' sleep quality, skin condition and life status after 4 weeks of using a sleep aid drink (AOXMED Poria γ-aminobutyric acid drink). This is a single-center, randomized, double-blind, controlled, 4-week (28-day) clinical study conducted in Chinese healthy women aged 25-55 years old who were offered a sleep aid drink.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05908903
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sleep Disorder
Currently open trials in the same condition.
- NCT07485790 — The Effects of Yoga on Pregnant Women · NA · recruiting
- NCT06990256 — Evaluation of Urolithin A and Fisetin on Improving Sleep and Aging Biomarkers · NA · recruiting
- NCT04949360 — SleepUp Digital CBTi-based Platform for Insomnia · NA · recruiting
- NCT05649514 — Sleep Impairment in Subjects at Risk of Developing Alzheimer's Disease · NA · recruiting
- NCT06914466 — Neural Mechanisms and Clinical Applications of DBS for Modulating Sleep Dysregulation in PD · recruiting
Other Botanee Group Co., Ltd. trials
Trials by the same sponsor.
- NCT06891924 — A Clinical Study on Pre-operative Intervention With Products During Aesthetic Medicine · NA · not yet recruiting
- NCT06188338 — A 56-day Clinical Study on Facial Skin Rejuvenation · NA · completed
- NCT06140628 — A 28-day Clinical Study on Facial Skin Rejuvenation · NA · completed
- NCT06274450 — A Clinical Study on the Improvement of Skin and Living Conditions After Drinking Rosa Roxburghii and Pomegranate Drinks · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05908903 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Botanee Group Co., Ltd.
- Last refreshed: 18 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05908903.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing